[{"indications": "Indications\u00a0monotherapy and adjunctive treatment of focal seizures with or without\r\nsecondary generalisation; peripheral neuropathic pain (section 4.7.3); migraine prophylaxis [unlicensed] (section 4.7.4.2)", "name": "GABAPENTIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.1 Control of the epilepsies", "Gabapentin and pregabalin", "GABAPENTIN"], "cautions": "Cautions\u00a0avoid abrupt withdrawal; elderly; diabetes mellitus; mixed seizures (including absences); false positive\r\nreadings with some urinary protein tests; history of psychotic illness; interactions: Appendix 1 (gabapentin)", "side-effects": "Side-effects\u00a0nausea, vomiting, gingivitis, diarrhoea, abdominal\r\npain, dyspepsia, constipation, dry mouth or throat, flatulence, weight\r\ngain, increased appetite, anorexia, hypertension, vasodilatation,\r\noedema, dyspnoea, cough, pharyngitis, hostility, confusion, emotional\r\nlability, depression, vertigo, anxiety, nervousness, abnormal thoughts,\r\ndrowsiness, dizziness, malaise, ataxia, convulsions, movement disorders, speech disorder,\r\namnesia, tremor, insomnia, headache, paraesthesia, nystagmus, abnormal\r\nreflexes, fever, flu syndrome, impotence, leucopenia, arthralgia,\r\nmyalgia, twitching, visual disturbances, rhinitis, rash, pruritus,\r\nacne; less commonly palpitation; also reported pancreatitis, hepatitis, hallucinations, blood glucose fluctuations\r\nin patients with diabetes, breast hypertrophy, gynaecomastia, acute\r\nrenal failure, incontinence, thrombocytopenia, tinnitus, Stevens-Johnson\r\nsyndrome, alopecia, hypersensitivity syndrome; suicidal ideation", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129255.htm", "doses": ["Epilepsy, 300\u00a0mg once daily on day 1, then 300\u00a0mg\r\ntwice daily on day 2, then 300\u00a0mg 3 times daily on day 3 or initially 300\u00a0mg 3 times daily on day 1; then increased according\r\nto response in steps of 300\u00a0mg (in 3 divided doses) every 2\u20133 days;\r\nusual dose 0.9\u20133.6\u00a0g daily in 3 divided doses (max. 4.8\u00a0g daily in\r\n3 divided doses); child 6\u201312 years\r\n(adjunctive therapy only) initially 10\u00a0mg/kg (max. 300\u00a0mg) once daily\r\non day 1, then 10\u00a0mg/kg (max. 300\u00a0mg) twice daily on day 2, then 10\u00a0mg/kg\r\n(max. 300\u00a0mg) 3 times daily on day 3; usual dose 25\u201335\u00a0mg/kg daily\r\nin 3 divided doses; max. 70\u00a0mg/kg daily in 3 divided doses; child 2\u20136 years see BNF for Children", "Neuropathic pain, adult over 18 years, 300\u00a0mg once daily on day 1, then 300\u00a0mg twice daily\r\non day 2, then 300\u00a0mg 3 times daily on day 3 or initially\r\n300\u00a0mg 3 times daily on day 1, then increased according to response\r\nin steps of 300\u00a0mg (in 3 divided doses) every 2\u20133 days up to max.\r\n3.6\u00a0g daily", "Migraine prophylaxis [unlicensed], initially 300\u00a0mg\r\ndaily, increased according to response up to 2.4\u00a0g daily in divided\r\ndoses"], "pregnancy": "Pregnancy\u00a0see Pregnancy"}]